Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 31551-31600 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06440902
Exploration of Therapeutic Strategies for NeoRAS Wild-type Metastatic Colorectal Cancer Based on Circulating Tumor DNA
PHASE2Recruiting
1,100 participants
Started: Dec 28, 2023 · Completed: Sep 1, 2028
1 condition1 sponsor1 location
NCT06352801
Effectiveness of Self-Compassion Intervention on Enhancing Self-Compassion and Psychological Well-Being of Children With Attention Deficit/Hyperactivity Disorder
NARecruiting
100 participants
Started: Dec 28, 2023 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT06172322
A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer
PHASE1Recruiting
42 participants
Started: Dec 28, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06169371
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
PHASE4Recruiting
50 participants
Started: Dec 28, 2023 · Completed: Nov 30, 2030
1 condition1 sponsor2 locations
NCT06148896
Combining Physiotherapy Group Exercise With Acceptance and Commitment Therapy in Elderly With Chronic Low Back Pain
NARecruiting
86 participants
Started: Dec 28, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06241755
Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
PHASE3Recruiting
412 participants
Started: Dec 28, 2023 · Completed: Sep 3, 2026
1 condition2 sponsors1 location
NCT05997017
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
PHASE2Recruiting
29 participants
Started: Dec 28, 2023 · Completed: Oct 31, 2026
6 conditions1 sponsor9 locations
NCT06153420
Study of the Research Medicine CIN-103 in Adults with Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D).
PHASE2Recruiting
450 participants
Started: Dec 28, 2023 · Completed: Dec 9, 2025
1 condition1 sponsor53 locations
NCT06050369
Objective Characterizatoion of Repetitive Behaviors
NARecruiting
50 participants
Started: Dec 28, 2023 · Completed: Dec 27, 2027
3 conditions1 sponsor3 locations
NCT06197178
A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC)
PHASE1Recruiting
42 participants
Started: Dec 28, 2023 · Completed: Mar 31, 2028
1 condition2 sponsors2 locations
NCT06002607
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
N/ARecruiting
50 participants
Started: Dec 28, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT06716983
Multimodal Investigation of Cortico-Basal Ganglia-Thalamo-Cortical Network Dynamics in Dystonic Patients with Deep Brain Stimulation
N/ARecruiting
15 participants
Started: Dec 28, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05441280
Pimavanserin for Insomnia in Veterans With PTSD
PHASE2Recruiting
60 participants
Started: Dec 28, 2023 · Completed: Jul 12, 2027
2 conditions1 sponsor1 location
NCT06168851
Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
PHASE2Recruiting
20 participants
Started: Dec 28, 2023 · Completed: Dec 31, 2025
2 conditions3 sponsors1 location
NCT06148506
A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia
N/ARecruiting
376 participants
Started: Dec 28, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor21 locations
NCT06279741
Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants
PHASE1/PHASE2Recruiting
265 participants
Started: Dec 28, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor8 locations
NCT06129240
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
N/ARecruiting
60 participants
Started: Dec 28, 2023 · Completed: Oct 31, 2026
2 conditions1 sponsor23 locations
NCT06174363
Analgesic Efficacy of Maxigesic in Breast Cancer Surgery
NARecruiting
84 participants
Started: Dec 28, 2023 · Completed: Dec 26, 2025
1 condition1 sponsor1 location
NCT06217900
a PROspective Case Control Study to Develop and Validate a Blood Test FOr mUlti-caNcers Early Detection(PROFOUND)
N/ARecruiting
16,666 participants
Started: Dec 28, 2023 · Completed: Mar 31, 2027
1 condition2 sponsors2 locations
NCT05905328
Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy
PHASE1/PHASE2Recruiting
54 participants
Started: Dec 28, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor6 locations
NCT05910177
Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin
PHASE2Recruiting
30 participants
Started: Dec 28, 2023 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT06260397
Serratus Anterior Plane Block and Costotransverse Block for Analgesia Following Modified Radical Mastectomy Surgeries
NARecruiting
90 participants
Started: Dec 28, 2023 · Completed: Mar 30, 2025
1 condition1 sponsor1 location
NCT06282341
Fatigue and Recovery: a Comparison Between Trail and Marathon
NARecruiting
90 participants
Started: Dec 28, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06149286
A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
PHASE3Recruiting
470 participants
Started: Dec 28, 2023 · Completed: Jan 23, 2029
2 conditions1 sponsor158 locations
NCT06234397
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
PHASE1Recruiting
245 participants
Started: Dec 28, 2023 · Completed: Jan 31, 2028
1 condition2 sponsors8 locations
NCT06200220
Patients Treated in Real Life With VEnetoclax for WAldenström Macroglobulinemia
N/ARecruiting
45 participants
Started: Dec 28, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT06174532
Virtual Surgical Planning in Mandibular Segmental Resection
NARecruiting
30 participants
Started: Dec 27, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06141486
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
PHASE3Recruiting
900 participants
Started: Dec 27, 2023 · Completed: Mar 24, 2028
1 condition1 sponsor321 locations
NCT06913998
The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease
N/ARecruiting
65 participants
Started: Dec 27, 2023 · Completed: Nov 30, 2026
3 conditions1 sponsor1 location
NCT06693973
An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
EARLY_PHASE1Recruiting
13 participants
Started: Dec 27, 2023 · Completed: Jan 13, 2026
1 condition2 sponsors1 location
NCT06223880
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
PHASE4Recruiting
350 participants
Started: Dec 27, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor40 locations
NCT06969742
Development and Application of Intervention Program to Improve Mental Health and Quality of Life of Solid Tumor Survivors and Caregivers
NARecruiting
120 participants
Started: Dec 27, 2023 · Completed: Dec 31, 2028
1 condition3 sponsors3 locations
NCT06010329
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
PHASE2Recruiting
66 participants
Started: Dec 27, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor9 locations
NCT06072807
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
PHASE4Recruiting
20 participants
Started: Dec 27, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06173505
Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC
PHASE1/PHASE2Recruiting
168 participants
Started: Dec 27, 2023 · Completed: Oct 31, 2027
1 condition1 sponsor43 locations
NCT06201741
A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer
NARecruiting
10 participants
Started: Dec 27, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT06182527
Relevance of Reactive Hypoglycemia During an OGTT in Everyday Life Using Continuous Glucose Measurement
NARecruiting
20 participants
Started: Dec 27, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06220552
The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
PHASE2Recruiting
20 participants
Started: Dec 27, 2023 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT06394076
A Study to Evaluate the Safety and Effectiveness of Injectable Gel for Correction of Infraorbital Hollowing in Chinese Population
NARecruiting
172 participants
Started: Dec 27, 2023 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05691465
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
PHASE2Recruiting
30 participants
Started: Dec 27, 2023 · Completed: Nov 1, 2025
4 conditions1 sponsor13 locations
NCT05758896
Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI
PHASE2Recruiting
280 participants
Started: Dec 27, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor14 locations
NCT06201117
Effects of Preparatory Information on Anxiety and Treatment Adherence in Heart Surgery Patients
NARecruiting
48 participants
Started: Dec 27, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT06874530
Efficacy of Isatuximab-based Regimens in Relapsed/Refractory Multiple Myeloma With 1q21+
N/ARecruiting
30 participants
Started: Dec 27, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06059638
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NARecruiting
500 participants
Started: Dec 27, 2023 · Completed: Aug 31, 2029
3 conditions2 sponsors78 locations
NCT06087627
A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine
N/ARecruiting
150 participants
Started: Dec 27, 2023 · Completed: Dec 28, 2026
1 condition1 sponsor11 locations
NCT06142552
Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein
PHASE3Recruiting
120 participants
Started: Dec 27, 2023 · Completed: Sep 1, 2026
1 condition1 sponsor28 locations
NCT06569589
Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat
N/ARecruiting
80 participants
Started: Dec 27, 2023 · Completed: Aug 31, 2026
3 conditions4 sponsors4 locations
NCT06201000
Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients
N/ARecruiting
282 participants
Started: Dec 27, 2023 · Completed: Sep 1, 2024
2 conditions4 sponsors1 location
NCT06008691
A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
N/ARecruiting
1,500 participants
Started: Dec 27, 2023 · Completed: Oct 31, 2038
1 condition2 sponsors61 locations
NCT06053567
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
PHASE3Recruiting
360 participants
Started: Dec 27, 2023 · Completed: Jun 30, 2028
1 condition5 sponsors1 location